LAMTOR5 and breast carcinoma: The levels of HBXIP that can compete with Nrf-2 for binding with Keap1 protein, via its highly conserved GLNLG motif, are positively correlated with Nrf-2 expression in breast cancer cells and clinical breast cancer tissue samples [342].